Industry
Biotechnology
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Avi Kapoor
April 08, 2024 | 12:00 pm
Portfolio Pulse from Benzinga Newsdesk
April 08, 2024 | 11:38 am
Portfolio Pulse from Benzinga Newsdesk
March 28, 2024 | 12:48 pm
Portfolio Pulse from Benzinga Newsdesk
March 28, 2024 | 12:35 pm
Portfolio Pulse from Benzinga Insights
March 21, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
March 05, 2024 | 1:01 pm
Portfolio Pulse from Benzinga Newsdesk
February 15, 2024 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
February 07, 2024 | 1:35 pm
Portfolio Pulse from Benzinga Insights
November 06, 2023 | 1:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.